Monkeypox outbreak may boost handful of companies

Shares of vaccine producers, antiviral drug makers, and protective equipment manufacturers are in demand
Monkeypox outbreak may boost handful of companies

Tedros Adhanom Ghebreyesus, director of the WHO, which declared the spread of monkeypox infections as a global emergency.

As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit from the race to quell the disease.

Shares of vaccine producers, antiviral drug makers, and protective equipment manufacturers are in demand as investors tap a strategy that delivered gains during the coronavirus pandemic.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited